药物相关性血栓性血小板减少性紫癜/溶血尿毒症综合征
被引量：2
Drug-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome
摘要
药物相关性血栓性血小板减少性紫癜/溶血尿毒症综合征(TTP/HUS)的发病机制主要为免疫介导或药物的直接毒性作用,不同药物引起TTP/HUS的临床表现和预后有所不同。目前有必要制订药物相关性TTP/HUS的诊断标准和治疗方案,以便及时、准确地做出诊断,并尽早给予合理治疗。
出处
《药物不良反应杂志》
2004年第6期361-365,共5页
Adverse Drug Reactions Journal
参考文献35
-
1Snyder HW Jr, Mittelman A, Oral A, et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma[J]. Cancer, 1993,71 (5):1882.
-
2Vesely SK, George JN, Lammle B, et al. ADAMTS13activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients[J].Blood, 2003,102(1):60.
-
3Tsai HM, Rice L, Sarode R, et al. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of yon Willebrand factor to platelets in ticlopidineassociated thrombotic thrombocytopenic purpura[J]. Ann Intern Med, 2000,132(10):794.
-
4Steinhubl SR, Tan WA, Foody JM, et al. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet Ⅱb/Ⅲa Inhibitor for Stenting [J]. JAMA, 1999, 281(
-
5Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrodrome[J]. Curr Opin Hematol, 2001,8(5):286.
-
6Nagaya S, Wada H, Oka K, et al. Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C[J].Am J Hematol, 1995,50(4):237.
-
7Gulati SC, Sordillo P, Kempin S, et al. Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil[J]. Cancer, 1980, 45(9):2252.
-
8Lempert KD. Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin C [J]. Lancet,1980, 2(1890):369.
-
9Korec S, Schein PS, Smith FP, et al. Treatment of cancerassociated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion[J]. J Clin Oncol, 1986, 4(2):210.
-
10Page Y, Tardy B, Zeni F, et al. Thrombotic thrombocytopenic purpura related to ticlopidine[J]. Lancet ,1991,337(8477):774.
同被引文献9
-
1Gasser C,Gautie RE,Steek A,et al. Hemolytie-uremie syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia Schweiz[J]. Med Wschr,1955 85(38) 905-909.
-
2王海燕.肾脏病学[M1.北京:人民卫生出版社,2008:1539-1544.
-
3马济民.溶血性尿毒症综锱正的发病机理和治疗近况.肾脏病与透析肾移植杂志,1999,2(9):265-265.
-
4高春林,刘光陵,夏正坤,傅元凤,伏洁,高远赋,张连丰,樊忠民,任献国.溶血尿毒综合征的临床与病理分析[J].天津医药,2007,35(8):606-607. 被引量：3
-
5袁伟杰,郭云珊.溶血尿毒症综合征的诊治思路[J].中国实用内科杂志,2007,27(22):1805-1807. 被引量：5
-
6中华人民共和国卫生部.药品不良反应报告和监测管理办法 中华人民共和国卫生部令81号[Z].
-
7孔秀岩,苏志刚.溶血性尿毒症综合征的肾损害[J].河北医药,2009,31(4):473-475. 被引量：6
-
8翟广,李波,李玉芹,刘亚男,寇长贵,姚燕,赵书欣.利福喷丁与利福平治疗肺结核疗效和安全性的Meta分析[J].吉林大学学报（医学版）,2011,37(3):523-528. 被引量：40
-
9耿晓剑,兰志宏.黄芪对肾病综合征患者血浆蛋白及尿蛋白的影响[J].现代中西医结合杂志,2001,10(23):2264-2265. 被引量：3
二级引证文献3
-
1张艳丛,邢洁.利福霉素致药物性溶血的临床特点和防治[J].吉林医学,2013,34(27):5609-5610.
-
2白大鹏,孔伟利,李丽.利福平致急性肾功能衰竭、血小板减低并肝功能异常1例[J].临床荟萃,2014,29(6):627-629. 被引量：5
-
3朱文忠,夏军.一例万古霉素与抗结核药物联合用药引起急性肾损伤的案例分析[J].黑龙江医学,2018,42(11):1126-1127. 被引量：1
-
1吴必嘉,郭天剑.主要表现为腹痛的血栓性血小板减少性紫癜／溶血尿毒症综合征1例[J].医学信息,2011,24(5):1348-1348.
-
2梁文学,尹良红,陈湛华,陈宇,孟宇.双重滤过血浆置换治疗血栓性血小板减少性紫癜／溶血尿毒症综合征一例[J].中华肾脏病杂志,2013,29(11):875-876. 被引量：3
-
3刘随意,傅鹏,彭旭东,阳青松,赵慧,崔若兰.酗酒致急性胰腺炎并溶血尿毒症综合征一例[J].中华肾脏病杂志,2009,25(5):362-362.
-
4袁红伶,周晓萍,徐剑,张金黎.溶血尿毒综合征并发脑血管事件1例分析[J].中国误诊学杂志,2008,8(22):5508-5508. 被引量：1
-
5西登彬.血栓性血小板减少性紫癜—溶血尿毒症综合征误诊为肾综合征出血热1例[J].中国实用内科杂志,2001,21(10):637-637.
-
6吴必嘉,郭天剑.以腹痛为主要表现的血栓性血小板减少性紫癜/溶血尿毒症综合征1例[J].血栓与止血学,2008,14(6):285-285.
-
7Vesely SK,Li XN,Mcminn JR,赵凤绵,张燕,董碧晨.血栓性血小板减少性紫癜-溶血尿毒症综合征恢复后妊娠者的预后[J].国外医学（输血及血液学分册）,2005,28(3):264-267.
-
8林宛兵,陈楠.血栓性微血管病发病机制及分类新认识[J].中国实用内科杂志,2011,31(10):799-801. 被引量：8
-
9张锋,张澎,李彬.血液透析治疗急性肾衰竭49例临床观察[J].宁夏医学杂志,2011,33(8):752-754. 被引量：3
-
10袁伟杰,郭云珊.溶血尿毒症综合征的诊治思路[J].中国实用内科杂志,2007,27(22):1805-1807. 被引量：5
